Outcome of AML Patients Treated with 5 or 10 Days of Decitabine Plus Venetoclax: A Single Center Experience

Authors :: Jieying Liu
Mengni Guo
Nahir Rivera-Robles
Natalie Giron
Baylee Bryan
Zohaib Ahmed
Anum Jalil
Rushang D Patel
Juan C. Varela
Shahram Mori
Source :: Transplantation and Cellular Therapy. 28:S136-S137
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Tools